stars 1 stars 2 stars 3

FutureMeds is an independent, fully-owned European Site Network and DCT service provider dedicated to running patient-centric clinical trials and delivering quality data for the world’s leading Sponsors & CROs. With 29 strategically located sites across 7 countries, over 220 experienced investigators, and more than 1400 homecare providers, FutureMeds offers site and DCT solutions across most therapeutic areas and provides reliability, efficiency and accuracy to help clients accelerate patient access to new treatments. To learn more about how FutureMeds can support your trial, reach out to our team or visit futuremeds.com LinkedIn Privacy Policy: https://www.futuremeds.com/linkedin-privacy-policy

FutureMeds Questions

The FutureMeds annual revenue was $7.6 million in 2026.

Radoslaw Janiak is the CEO of FutureMeds.

232 people are employed at FutureMeds.

Top FutureMeds Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users